Altimmune (ALT) said Wednesday that Chief Financial Officer Richard Eisenstadt died on June 24.
The clinical-stage biopharmaceutical company said Eisenstadt's responsibilities will be performed by its finance and accounting team while Altimmune searches for a successor.
The company's shares were down nearly 2.3% in recent Wednesday premarket activity.
Price: 7.24, Change: -0.17, Percent Change: -2.29